Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Javid J Moslehi"'
Autor:
Joe-Elie Salem, Solange Peters, Olivier Michielin, Hasna Bouchaab, Javid J Moslehi, Sofiya Latifyan, Matthieu Perreau, John O Prior, Craig Fenwick, Sarah Boughdad, Madeleine Suffiotti, Niklaus Schaefer, Marie Nicod-Lalonde, Julien Costes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/940630054940454ebfbd50db6c1cad87
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immune checkpoint inhibitors (ICIs) have transformed treatment for melanoma, but identifying reliable biomarkers of response and effective modifiable lifestyle factors has been challenging. Obesity has been correlated with improved respons
Externí odkaz:
https://doaj.org/article/6dbe377bca014a8e9c17dfb7bb086289
Autor:
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, Alban Redheuil, Samia Boussouar, Lee S. Nguyen, Adrien Procureur, Frederic Stein, Charlotte Fenioux, Perrine Devos, Paul Gougis, Martin Dres, Alexandre Demoule, Dimitri Psimaras, Timothee Lenglet, Thierry Maisonobe, Marc Pineton De Chambrun, Guillaume Hekimian, Christian Straus, Jesus Gonzalez-Bermejo, David Klatzmann, Aude Rigolet, Perrine Guillaume-Jugnot, Nicolas Champtiaux, Olivier Benveniste, Nicolas Weiss, Samir Saheb, Philippe Rouvier, Isabelle Plu, Estelle Gandjbakhch, Mathieu Kerneis, Nadjib Hammoudi, Noel Zahr, Claudia Llontop, Capucine Morelot-Panzini, Lorenz Lehmann, Juan Qin, Javid J. Moslehi, Michelle Rosenzwajg, Thomas Similowski, Yves Allenbach
Publikováno v:
Cancer discovery, vol 13, iss 5
Immune-checkpoint-inhibitor (ICI)–associated myotoxicity involves the heart (myocarditis) and skeletal muscles (myositis), which frequently occur concurrently and are highly fatal. We report the results of a strategy that included identification of
Autor:
Chen Chen, Feng Wang, Peng Chen, Jiangang Jiang, Guanglin Cui, Ning Zhou, Francesco Moroni, Javid J. Moslehi, Enrico Ammirati, Dao Wen Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 21 (2020)
Background There has been significant controversy about the effects of pre‐hospitalization use of renin‐angiotensin system (RAS) inhibitors on the prognosis of patients with hypertension and coronavirus disease 2019. Methods and Results We retros
Externí odkaz:
https://doaj.org/article/644824c8e7824da0a3903c537153f1e8
Autor:
Yves Allenbach, Thomas Similowski, Michelle Rosenzwajg, Javid J. Moslehi, Juan Qin, Lorenz Lehmann, Capucine Morelot-Panzini, Claudia Llontop, Noel Zahr, Nadjib Hammoudi, Mathieu Kerneis, Estelle Gandjbakhch, Isabelle Plu, Philippe Rouvier, Samir Saheb, Nicolas Weiss, Olivier Benveniste, Nicolas Champtiaux, Perrine Guillaume-Jugnot, Aude Rigolet, David Klatzmann, Jesus Gonzalez-Bermejo, Christian Straus, Guillaume Hekimian, Marc Pineton De Chambrun, Thierry Maisonobe, Timothee Lenglet, Dimitri Psimaras, Alexandre Demoule, Martin Dres, Paul Gougis, Perrine Devos, Charlotte Fenioux, Frederic Stein, Adrien Procureur, Lee S. Nguyen, Samia Boussouar, Alban Redheuil, Stéphane Ederhy, Sarah Leonard-Louis, Baptiste Abbar, Marie Bretagne, Joe-Elie Salem
Treatment modalities and reported adverse events by quartile of period of inclusion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5c53713e30354ea46b0e124d10b81e3
https://doi.org/10.1158/2159-8290.22758863.v1
https://doi.org/10.1158/2159-8290.22758863.v1
Autor:
Yves Allenbach, Thomas Similowski, Michelle Rosenzwajg, Javid J. Moslehi, Juan Qin, Lorenz Lehmann, Capucine Morelot-Panzini, Claudia Llontop, Noel Zahr, Nadjib Hammoudi, Mathieu Kerneis, Estelle Gandjbakhch, Isabelle Plu, Philippe Rouvier, Samir Saheb, Nicolas Weiss, Olivier Benveniste, Nicolas Champtiaux, Perrine Guillaume-Jugnot, Aude Rigolet, David Klatzmann, Jesus Gonzalez-Bermejo, Christian Straus, Guillaume Hekimian, Marc Pineton De Chambrun, Thierry Maisonobe, Timothee Lenglet, Dimitri Psimaras, Alexandre Demoule, Martin Dres, Paul Gougis, Perrine Devos, Charlotte Fenioux, Frederic Stein, Adrien Procureur, Lee S. Nguyen, Samia Boussouar, Alban Redheuil, Stéphane Ederhy, Sarah Leonard-Louis, Baptiste Abbar, Marie Bretagne, Joe-Elie Salem
Example of the first severe ICI-myocarditis case treated with abatacept guided by real-time immune-monitoring assessment of CD86RO (CD86 receptor occupancy) on circulating monocytes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21bb07722f4a142a6cdb99209d35e88
https://doi.org/10.1158/2159-8290.22758887
https://doi.org/10.1158/2159-8290.22758887
Autor:
Yves Allenbach, Thomas Similowski, Michelle Rosenzwajg, Javid J. Moslehi, Juan Qin, Lorenz Lehmann, Capucine Morelot-Panzini, Claudia Llontop, Noel Zahr, Nadjib Hammoudi, Mathieu Kerneis, Estelle Gandjbakhch, Isabelle Plu, Philippe Rouvier, Samir Saheb, Nicolas Weiss, Olivier Benveniste, Nicolas Champtiaux, Perrine Guillaume-Jugnot, Aude Rigolet, David Klatzmann, Jesus Gonzalez-Bermejo, Christian Straus, Guillaume Hekimian, Marc Pineton De Chambrun, Thierry Maisonobe, Timothee Lenglet, Dimitri Psimaras, Alexandre Demoule, Martin Dres, Paul Gougis, Perrine Devos, Charlotte Fenioux, Frederic Stein, Adrien Procureur, Lee S. Nguyen, Samia Boussouar, Alban Redheuil, Stéphane Ederhy, Sarah Leonard-Louis, Baptiste Abbar, Marie Bretagne, Joe-Elie Salem
Methods concerning Immune-checkpoint proteins profiling on peripheral blood mononuclear cells and Circulating immune checkpoint agents drug monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c0774fa3619f561f94b81218103a59
https://doi.org/10.1158/2159-8290.22758884.v1
https://doi.org/10.1158/2159-8290.22758884.v1
Autor:
Brian I. Rini, Javid J. Moslehi, Marc Bonaca, Manuela Schmidinger, Laurence Albiges, Toni K. Choueiri, Robert J. Motzer, Michael B. Atkins, John Haanen, Mariangela Mariani, Jing Wang, Subramanian Hariharan, James Larkin
Publikováno v:
Journal of Clinical Oncology. 40:1929-1938
PURPOSE Both immune checkpoint inhibitors (ICIs) and vascular endothelial growth factor receptor (VEGFR) inhibitors are approved for advanced renal cell carcinoma treatment and can cause cardiovascular events (CVs); thus, combination therapy could le
Autor:
Yves Allenbach, Thomas Similowski, Michelle Rosenzwajg, Javid J. Moslehi, Juan Qin, Lorenz Lehmann, Capucine Morelot-Panzini, Claudia Llontop, Noel Zahr, Nadjib Hammoudi, Mathieu Kerneis, Estelle Gandjbakhch, Isabelle Plu, Philippe Rouvier, Samir Saheb, Nicolas Weiss, Olivier Benveniste, Nicolas Champtiaux, Perrine Guillaume-Jugnot, Aude Rigolet, David Klatzmann, Jesus Gonzalez-Bermejo, Christian Straus, Guillaume Hekimian, Marc Pineton De Chambrun, Thierry Maisonobe, Timothee Lenglet, Dimitri Psimaras, Alexandre Demoule, Martin Dres, Paul Gougis, Perrine Devos, Charlotte Fenioux, Frederic Stein, Adrien Procureur, Lee S. Nguyen, Samia Boussouar, Alban Redheuil, Stéphane Ederhy, Sarah Leonard-Louis, Baptiste Abbar, Marie Bretagne, Joe-Elie Salem
Immune-checkpoint-inhibitor (ICI)–associated myotoxicity involves the heart (myocarditis) and skeletal muscles (myositis), which frequently occur concurrently and are highly fatal. We report the results of a strategy that included identification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d12c6ce6fd521a88cae8cee6787353
https://doi.org/10.1158/2159-8290.c.6611463.v1
https://doi.org/10.1158/2159-8290.c.6611463.v1
Autor:
Douglas B. Johnson, Joe-Elie Salem, Justin M. Balko, Javid J. Moslehi, Fei Ye, Haocan Song, Kaustav P. Shah
Immune checkpoint inhibitors (ICI) are now routinely used in multiple cancers but may induce autoimmune-like side effects known as immune-related adverse events (irAE). Although classical autoimmune diseases have well-known risk factors, including ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af049d0dfbf485bccc6b7d74a9f6a8f
https://doi.org/10.1158/2326-6066.c.6550500.v1
https://doi.org/10.1158/2326-6066.c.6550500.v1